Home > Financial Ratios > GLAND PHARMA
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) -4.679.11-34.6021.3433.82

What is the latest EBIT Growth ratio of GLAND PHARMA ?

The latest EBIT Growth ratio of GLAND PHARMA is -4.67 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025-4.67
Mar20249.11
Mar2023-34.60
Mar202221.34
Mar202133.82

How is EBIT Growth of GLAND PHARMA Trending?

Years EBIT Growth % Change
Mar2025 -4.67
Negative
Mar2024 9.11
Positive
Mar2023 -34.6
Negative
Mar2022 21.34
-36.90
Mar2021 33.82 -

Other Financial Ratios of GLAND PHARMA


Compare EBIT Growth ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹28,856.5 Cr 2.1% 1.3% 19.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,848.0 Cr 11.6% 0.7% -0.4% Stock Analytics
DIVIS LABORATORIES ₹172,697.0 Cr 2.3% 8.5% 8.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,859.0 Cr 1.8% -1.8% 30.7% Stock Analytics
DR REDDYS LABORATORIES ₹110,421.0 Cr 0.5% 3.2% 13.3% Stock Analytics
CIPLA ₹105,811.0 Cr 1.2% 5.4% -13.7% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

2.1%

1.3%

19.7%

SENSEX

-1%

2.2%

-3.6%


You may also like the below Video Courses